![]() |
市场调查报告书
商品编码
1383499
2030 年医疗机器人市场预测:按类型、产品、配置、配销通路、应用、最终用户和地区进行的全球分析Medical Robotics Market Forecasts to 2030 - Global Analysis By Type, Product, Setting, Distribution channel, Application, End User and By Geography |
根据Stratistics MRC的数据,2023年全球医疗机器人市场规模为136.4亿美元,预计2030年将达到424.3亿美元,预测期内年复合成长率为17.6%。
医疗机器人是医院和其他医疗机构使用的专业服务机器人,旨在提高为患者提供的护理品质。有助于外科医师进行更准确、更有效的手术。它还最大限度地减少了医务人员的工作量,让他们有更多的时间照顾病人。
根据国家安全委员会 (NSC) 的数据,年度约有 160 万至 380 万名运动员遭受某种类型的身体伤害。
手术机器人已成为现代外科新的增长点和技术培养箱。机器人辅助手术的创建是为了克服当前微创手术技术的限製或提高外科医生在对患者开放性手术时的表现。微创手术中使用的手术机器人可以帮助减少疤痕、加速癒合并缩短恢復时间。由于对微创手术治疗的需求不断增加以及医疗机器人辅助手术过程的应用,手术现在变得更加有效。因此,这些因素正在推动市场成长。
在医疗机器人市场中,高昂的初始成本是一个重要的抑制因素,阻碍了市场的成长。机器人硬体,例如手术机器人和机器人辅助手术系统,初期成本可能难以承受。此外,医疗机器人的整合通常需要专用的手术室和基础设施的改变,这进一步增加了初始成本。然而,医务人员必须接受专门培训才能安全操作医疗机器人并执行手术。
透过利用机器人系统,药物输送变得更加精确、有针对性和高效。医疗机器人可以精确调整给药时间和给药量,确保适量到达所需区域。这对于需要极高精确度的医疗程序特别有用,例如静脉注射药物或癌症治疗。此外,机器人技术可以促进标靶药物输送,将药物特异性引导至受影响的组织和细胞,最大限度地减少与健康组织和细胞的接触。这种方法可以提高治疗效果,同时最大限度地减少副作用。这些因素正在推动市场需求。
医疗机器人需要定期维修、定期保养。为了避免代价高昂的中断,可靠的更换零件供应和熟练的维修技术人员至关重要。医疗机器人在诊断和手术等各种医疗保健场合中不可或缺。意外故障或故障可能会导致严重停机、延误患者治疗并给医护人员带来不便。医疗机器人的故障可能会导致错误、问题和不利结果,使病患安全面临风险。因此,维护和维修是市场需求的主要障碍。
COVID-19大流行对医疗机器人市场产生了重大影响。由于需要尽量减少人与人之间的接触,对医疗机器人的需求激增。随着用于远端医疗会诊和远端医疗的机器人的发展,远距医疗和远距医疗正在迅速普及,在保持社交距离的同时促进患者护理。也推出了使用 UV-C 光对医疗环境进行消毒并降低感染风险的机器人。在此期间,研究和开发加速,产生了用于样本采集、诊断和远端监控的机器人等创新。这次疫情也凸显了医疗机器人在透过模拟程序培训医护人员方面的作用。
腹腔镜部分估计占最大份额。腹腔镜设备已被证明是用于诊断和治疗目的的有效工具。人们注意到,包括腹腔镜手术在内的手术的资金和报销政策有所增加。近年来,机器人辅助腹腔镜手术越来越受欢迎。此外,由于腹腔镜手术具有切口小或无切口、住院时间短、疼痛减轻、恢復快、疤痕少、失血少等优点,机器人辅助微创手术的需求正在增加。
由于医院和诊所允许患者在一次就诊中获得所有类型的治疗选择和咨询,因此医院部门预计在预测期内将出现良好的增长。年度的医院和手术数量正在推动医院和诊所的成长。医疗机器人越来越多地用于手术、静脉注射准备、消毒、物流和诊断等各种任务,为医院和诊所市场做出了贡献。
由于其先进的医疗基础设施、强大的研发能力和大量的医疗机构,北美在预测期内占据了最大的市场占有率。该地区是技术创新的中心,许多知名医疗机器人製造商、学术机构和医疗机构不断挑战产业极限。北美在远端医疗、机器人辅助手术、復健机器人等技术创新方面处于世界领先地位,带动了该地区的市场需求。
由于已开发国家老年人口的增加和医疗保健的全球化,预计欧洲在预测期内将出现盈利成长。欧洲拥有众多医疗机器人研究设施和创新中心。为了加速医疗机器人技术的开发和实施,这些中心与学术机构和产业领导者合作。欧洲国家继续表现出对医疗保健投资的坚定承诺,为该地区的医疗机构提供财务支持。
According to Stratistics MRC, the Global Medical Robotics Market is accounted for $13.64 billion in 2023 and is expected to reach $42.43 billion by 2030 growing at a CAGR of 17.6% during the forecast period. Medical robots are professional service robots used in hospitals and other healthcare facilities to improve the quality of care given to patients. It facilitates more precise and effective operations by surgeons. They create a substantial operational procedure that offers efficacy and low-cost investments in healthcare amenities while also minimizing the workload of medical staff, releasing them to spend more time directly caring for patients.
According to the National Safety Council (NSC), it was stated that about 1.6 to 3.8 million athletes get some sort of physical injury annually.
Surgical robotics has emerged as a new growth point and technological incubator in modern surgery. Robot-assisted surgeries were created to overcome the limitations of current minimally invasive surgery technologies or to enhance the abilities of surgeons during open surgery on a patient. Surgical robotics used in minimally invasive surgery helps to minimize scarring, speed up healing, and shorten recovery times. Surgical operations are now much more effective due to the growing demand for minimally invasive surgical treatments and the application of medical robotics to assist with surgical procedures. As a result, these factors are promoting market growth.
High initial costs serve as a notable restraint in the medical robotics market, hindering its growth. Robotic hardware, like surgical robots or robotic-assisted surgery systems, can have unaffordable initial costs. Moreover, the integration of medical robots frequently requires specialized operating rooms and infrastructural changes, which raises the initial costs even more. However, healthcare personnel must complete specialized training in order to safely operate medical robots and carry out procedures.
By leveraging robotic systems, drug delivery becomes more precise, targeted, and efficient. Medical robots are able to precisely regulate when and how much medication is administered, ensuring that the appropriate amount reaches the intended site. This is particularly helpful for medical procedures that require extreme precision, like intravenous drug delivery or cancer therapy. Additionally, robotics can facilitate targeted drug delivery, which minimizes exposure to healthy tissues and cells by directing medication specifically to affected tissues or cells. This method increases the therapeutic effect while lowering side effects. These factors propel market demand.
Medical robots need regular repairs as well as routine maintenance. To avoid expensive interruptions, it is crucial to guarantee a steady supply of replacement parts and skilled technicians for maintenance. Medical robots are essential to many aspects of healthcare, such as diagnosis and surgery. Any unforeseen malfunction or breakdown can cause a large amount of downtime, which could delay patient care and be inconvenient for medical staff. Medical robot malfunctions have a chance to put patient safety at risk by causing mistakes, problems, or unfavourable outcomes. Therefore, maintenance and repair is a significant barrier to market demand.
The COVID-19 pandemic significantly influenced the medical robotics market. With the need to minimize human-to-human contact, the demand for medical robots surged. Telemedicine and telehealth saw rapid adoption, leading to the development of robots for remote consultations and surgeries, facilitating patient care while maintaining social distancing. Robots were also deployed for disinfection, utilizing UV-C light and other methods to sanitize healthcare environments, reducing the risk of transmission. This period accelerated research and development, spawning innovations like robots for sample collection, diagnostics, and remote monitoring. The pandemic also emphasized the role of medical robots in training healthcare professionals through simulated procedures.
The laparoscopy segment is estimated to hold the largest share. Laparoscopic devices have proven to be effective tools for diagnostic and therapeutic purposes. Increases in funding and reimbursement policies have been noted for surgeries involving laparoscopies. Robot-assisted laparoscopy procedures have become increasingly common in recent years. Additionally, due to the numerous advantages of laparoscopic surgery, including small or no incision, brief hospital stays, less pain, short recovery times, fewer wounds, and decreased blood loss, there is a growing need for robot-assisted minimally invasive surgery.
The hospitals segment is anticipated to have lucrative growth during the forecast period, due to hospitals and clinics provide patients with all types of treatment options and consultations in a single visit. The number of hospitals and surgeries performed annually is driving the growth in hospitals and clinics. The increasing use of medical robotics for a range of tasks, such as surgery, IV preparations, sterilization, logistics, diagnostics, and more, contributes to the hospitals and clinics market segment.
North America commanded the largest market share during the extrapolated period due to its sophisticated healthcare infrastructure, strong capacity for research and development, and sizable number of healthcare institutions. The region is a center for technological innovation, with many well-known medical robot producers, academic institutions, and medical facilities constantly pushing the boundaries of the industry. North America leads the world in telemedicine, robotic-assisted surgery, and rehabilitation robot innovations, which drives market demand in this region.
Europe is expected to witness profitable growth over the projection period, due to the increasing geriatric population in developed countries and the globalization of healthcare. Numerous medical robotics research facilities and innovation hubs are located in Europe. To promote the advancement of medical robotic technology development and implementation, these centers work with influential individuals in the industry as well as academic institutions. European nations continue to show a strong commitment to investing in healthcare, giving financial support to healthcare facilities in this region.
Some of the key players in the Medical Robotics Market include: Titan Medical Inc., Renishaw Plc, Medrobotics Corporation, OR Productivity plc, Hansen, Mazor Robotics, iRobot Corporation, Intuitive Surgical, Health Robotics SLR, Mako Surgical Corp., Stereotaxis Inc., Accuray, Varian Medical Systems, Smith & Nephew, Zimmer Biomet, Medtronic and Stryker.
In Sept 2022 - Titan Medical entered into a limited development program agreement with Medtronic, whereby Medtronic will assess the effectiveness of Titan's instruments and cameras in gynecological procedures aligning with Titan Medical's plan to focus on gynecological procedures as the initial application for its surgical robot.
In Nov 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants.
In June 2020, Accuracy (US) launched the Cyber Knife S7 System a next-generation CyberKnife platform with advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radio surgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.